Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic Subjects
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorSven Schneider, MD
About this trial
Nasal allergen study in patients aged 60+ with or without current respiratory allergy
Eligibility criteria
Qualifiers
General inclusion criteria Age ≥ 60 years Willingness to participate in the study and to follow the protocol Written informed consent Standard healthcare insurance Subjects should be available during the entire study period
Disqualifiers
- Evidence of acute, chronic, malignant or general diseases-assessed by asking the patient
A History of anaphylaxis
Utilization of leukotriene modifiers or long-acting antihistamines
Chronic or intermittent use of oral, inhaled, intramuscular or intravenous corticosteroids
Trial design
Treatments tested in this trial
- Not listed
Trial groups
152 Participants
are grouped into 3 trial groupsSponsors and collaborators
Sven Schneider, MD
Lead sponsor
Medical University of Vienna
Sponsor institution
Source ClinicalTrials.gov